Data Characteristics in this Domain
Infectious disease pharmacovigilance data comes from diverse sources. These include national drug adverse event monitoring centers, the World Health Organization's (WHO) VigiBase database, disease control and prevention centers' (CDC) epidemic reports, clinical studies published in medical journals, and pharmaceutical companies' internal drug safety databases. Data update frequencies vary. Epidemic-related reports may update daily, while adverse drug reaction monitoring data is typically released quarterly or annually.
In terms of document structure, adverse event reports often appear as structured tables. These include fields such as patient demographics, medication history, adverse event descriptions, diagnosis, treatment measures, and outcomes. Clinical research reports are often unstructured text, covering research methods, results, and discussion, including drug-infection interactions or adverse reactions.
Key fields include drug name, disease diagnosis, adverse reaction terms (e.g., MedDRA codes), report date, patient age, gender, and comorbidities. Units commonly used are milligrams (mg) and grams (g) for dosage, days (d) and hours (h) for time, and times per day for frequency.
Constraints on "Reference and Traceability" from these Characteristics
The diversity of infectious disease data poses challenges for unified management of reference sources. Unstructured clinical reports require advanced text parsing capabilities to extract key information and ensure reference accuracy.
Varying data update frequencies mean knowledge base synchronization strategies need flexible configuration. High-frequency epidemic data requires faster crawling and indexing cycles to ensure timely references. Professional terms like MedDRA codes in structured adverse event reports demand precise semantic matching capabilities to avoid referencing errors due to terminology differences.
The complexity of infectious diseases, such as co-infections and drug resistance, can lead to non-specific adverse reactions. This increases the difficulty of tracing back to specific literature. More refined similarity calculation and contextual association capabilities are needed to differentiate adverse events under various infection backgrounds. Protecting patient privacy also requires anonymizing sensitive information during referencing to ensure compliance.
Configuration Settings
| Configuration Item | Suggested Value | Rationale for this Value |
|---|---|---|
Chunk size (Segment Length) | 500-800 characters | Balances the description length of infectious disease adverse event reports with model processing capabilities, preventing information overload in a single reference. |
Chunk Overlap Length (Segment Overlap Length) | 100 characters | Ensures contextual continuity, especially when dealing with complex pathological descriptions and drug interactions, preventing information fragmentation. |
Similarity threshold (Similarity Threshold) | 0.75-0.85 | Descriptions of infectious disease adverse reactions have similarities but significant detail differences; a high threshold helps precise matching. |
Recall count (Recall Count) | 8-12 items | Considering multiple factors influencing infectious disease pharmacovigilance, increasing recall helps comprehensively cover potential reference sources. |
Rerank result count (Reranked Return Count) | 3-5 items | Combines model processing capabilities with user reading habits, selecting the most relevant references to improve answer quality. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Addresses the parsing needs of lengthy medical journal reports, ensuring complex documents can be processed completely. |
Three Common Pitfalls
- AI responses cite outdated or irrelevant epidemic data. This occurs because the knowledge base's crawling strategy is not optimized for high-frequency data sources, leading to delayed indexed content.
- The full response outputs a large amount of low-relevance reference content, even with a high
Similarity threshold(Similarity Threshold). This might be due to an overly coarse segmentation strategy, where a single document is split into too many unrepresentative fragments, or the vector model has a bias in understanding professional terminology. - Workflows encounter parsing errors when attempting to reference external HTTP API return data. This manifests as abnormal status codes or empty fields. The cause is usually that the API's returned data format does not match predefined parsing rules, or there are cross-origin restrictions or authentication failures.
How to Confirm Proper Configuration
- Test the system's ability to accurately identify and cite key drug names, disease diagnoses, and adverse reaction terms for different types of infectious disease adverse event reports. Verify the match between cited content and original literature.
- Simulate queries for recent infectious disease-related pharmacovigilance information. Check if the cited data sources are the latest versions and assess whether the timeliness of the cited content meets requirements.
- Randomly select queries containing complex medical terminology and multiple medication scenarios. Verify that the system accurately cites professional terms like MedDRA codes in its responses and can trace them back to specific literature sources.
The values provided are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.